|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
RITODRINES CARDIOVASCULAR EFFECTS LIKE CARDIAC ARRHYTHMIA & HYPOTENSION MAY BE POTENTIATED BY THE CONCURRENT USE OF THE DRUG
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
DILTIAZEM UNDERGOES BIOTRANSFORMATION BY CYTOCHROME P450 MIXED FUNCTION OXIDASE ; CO-ADMINISTRATION MAY RESULT IN INCREASED SERUM CONCENTRATION OF DILTIAZEM, PROBABLY DUE TO INHIBITED OXIDATIVE METABOLISM OF DILTIAZEM BY FLUVOXAMINE
|
BETABLOCKERS MAY INHIBIT THE EFFECT OF BETA-2 SYMPATHOMIMETICS LIKE RITODRINE
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|
CORTICOSTEROIDS IF USED CONCOMITANTLY MAY LEAD TO PULMONARY EDEMA
|